Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CELEBREX 200 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/CELEBREX 200 MG CAPSULAS DURAS

Approved

STANDARD

CELEBREX 200 MG CAPSULAS DURAS

Viatris Healthcare🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 9, 2023
Approval ID: d49ae28c76da6806
Company: Viatris Healthcare
Type: Standard

Approval Details

Approval Id: d49ae28c76da6806
Drug Cima Aemps Name: CELEBREX 200 MG CAPSULAS DURAS
Register Number: BE212317IP1
Holder Company Name: Viatris Healthcare
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/viatris-healthcare
Authorization Date: 2023-10-09
Dosage Form: CÁPSULA DURA
Dose: 200 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Viatris Healthcare
Company Detail Path: /organization/viatris-healthcare

Company Information

Pharmaceutical Company Name: VIATRIS HEALTHCARE
Country Name: France
City Name: lyon,auvergne rhone alpes,country_fr
Address: 1 RUE DE TURIN

Active Ingredients

CELECOXIB

200 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 9, 2023

Approval ID

d49ae28c76da6806

Type

Standard

Back to CIMA-AEMPS Approvals